Telacebec 600 mg for leprosy, multibacillary

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Trial registered. A trial in people is registered. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 5 Nov 2026: Trial registered, NCT07918573

The trials

NCT07918573: Telacebec in Adults With Multibacillary Leprosy (TEBULA Leprosy Trial)

State
Not started
Phase
Phase 2
People
120 planned
Started
Dec 2026
Primary completion
Nov 2028
Arms
Group C (Hight dose)
Results
None posted
  1. 5 Nov 2026: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Trial registered

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.